Issue Date: July 19, 2010
Brain Acquires Stake In Enzymicals
Industrial biotech firm Brain has acquired a minority stake in Enzymicals, which spun off in 2009 from the research group of biotechnology professor Uwe Bornscheuer of Ernst Moritz Arndt University, in Greifswald, Germany. Enzymicals is developing biocatalytic routes to fine and specialty chemicals. The companies will apply Brain’s enzyme libraries to industrial process development. In a similar move, Johnson Matthey recently bought the German university spin-off and biocatalysis company X-Zyme.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society